1[1]Bakshi RP, Galande S, Muniyappa K. Functional and regulatory characteristics of eukaryotic type Ⅱ DNA topoisomerase[J]. Grit Rev Biochem Mol Biol, 2001, 36(1): 1～37
2[2]Liu D, Huang CL, Kameyama K, et al. Topoisomerase Ⅱ agene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients[J]. Cancer, 2002,94(8): 2239～2247
3[3]Syahruddin E, Oguri T, Takahashi T, et al. Differential expression of DNA topoisomerase Ⅱα and Ⅱβgenes between small cell and non-small cell lung cancer [J]. Jpn J Cancer Res, 1998, 89(8): 855～861
4[4]Mirski SE, Voskoglou-Nomikos T, Young LC, et al. Simultaneous quantitation of toposomerase Ⅱ alpha and beta isoform mRNAs in lung tumour cells and normal and malignant lung tissue[J]. Lab Invest, 2000, 80(6): 787～795
5[5]Nakopoulou L, Lazaris AC, Kavantzas N, et al. DNA topoisomerase Ⅱ-alpha immunoreactivity as a marker of rumor aggressiveness in invasive breastcancer[J]. Pathobiology, 2000,68(3): 137～143
6[6]Dingemans AC, van Ark-OtteJ, Span S, et al. Topoisomerase Ⅱ alpha and other drug resistance markers in advanced non--small cell lung cancer[J]. Lung Cancer, 2001, 32(2):117～128
7[7]Dingemans AC, Witlox MA, Stallaert RA, et al. Expression of DNA topoisomerase Ⅱ alpha and topoisomerase Ⅱ beta genes predicts survival and response to chemotherapy in patients with small cell lung cancer[J]. Clin Cancer Res, 1999, 5(8): 2048～2058
8[8]Beck WT, Mo YY, Bhat UG. Cytotoxic signalling by inhibitors of DNA topoisomerase Ⅱ [J]. Biochem Soc Trans,2001, 29(Pt6): 702～703
9[9]Asano T, An T, Mayes J, et al. Transfection of human topoisomerase Ⅱ oin the etoposide resistent cells: transient increase in the sensitivity followed by down-regulation of the endogenous gene[J]. Biochems, 1996, 319(Pt1): 307～313
10[10]Brana MF, Cacho M, Gradillas A, et al. Intercalators as anticancer drugs[J]. Curr Pharm Des, 2001, 7(17):1745～1780
6A. Kathleen McClendon. DNA topoisomerase Ⅱ[J]. genotoxicity, and cancer Mutation Research 2007, 623: 83- 97.
7Lok RB. Anti-cancer Drug Design, 1987 (2)151-164.
8Cheng C. Conservation of structure and mechanism between eukaryotic topoisomerase Ⅰ and site-specific recombinases [ J ]. Cell, 1998,92 (6) : 841-850.
9Redinbo MR. Crystal structures of human topoisomerase Ⅰ in covalent and noncovalent complexes with DNA [J ]. Science, 1998, 279 (5356): 1504-1513.
10Stewart L. A model for the mechanism of human topoisomerase Ⅰ [J]. Science , 1998, 279(5356): 1534-1541.
